BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11847592)

  • 1. Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient.
    Kubota R; Soldan SS; Martin R; Jacobson S
    J Neurovirol; 2002 Feb; 8(1):53-7. PubMed ID: 11847592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An altered peptide ligand antagonizes antigen-specific T cells of patients with human T lymphotropic virus type I-associated neurological disease.
    Kubota R; Soldan SS; Martin R; Jacobson S
    J Immunol; 2000 May; 164(10):5192-8. PubMed ID: 10799878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase.
    Biddison WE; Kubota R; Kawanishi T; Taub DD; Cruikshank WW; Center DM; Connor EW; Utz U; Jacobson S
    J Immunol; 1997 Aug; 159(4):2018-25. PubMed ID: 9257869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population.
    Best I; López G; Talledo M; MacNamara A; Verdonck K; González E; Tipismana M; Asquith B; Gotuzzo E; Vanham G; Clark D
    AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1207-12. PubMed ID: 21453202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
    Elovaara I; Koenig S; Brewah AY; Woods RM; Lehky T; Jacobson S
    J Exp Med; 1993 Jun; 177(6):1567-73. PubMed ID: 8496677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.
    Utz U; Banks D; Jacobson S; Biddison WE
    J Virol; 1996 Feb; 70(2):843-51. PubMed ID: 8551623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis.
    Daenke S; Kermode AG; Hall SE; Taylor G; Weber J; Nightingale S; Bangham CR
    Virology; 1996 Mar; 217(1):139-46. PubMed ID: 8599198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients.
    Greten TF; Slansky JE; Kubota R; Soldan SS; Jaffee EM; Leist TP; Pardoll DM; Jacobson S; Schneck JP
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7568-73. PubMed ID: 9636190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
    Höger TA; Jacobson S; Kawanishi T; Kato T; Nishioka K; Yamamoto K
    J Immunol; 1997 Aug; 159(4):2042-8. PubMed ID: 9257872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.
    Parker CE; Daenke S; Nightingale S; Bangham CR
    Virology; 1992 Jun; 188(2):628-36. PubMed ID: 1374983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
    J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system.
    Levin MC; Jacobson S
    J Neurovirol; 1997 Apr; 3(2):126-40. PubMed ID: 9111175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Kubota R; Jacobson S
    J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I.
    Bangham CR; Hall SE; Jeffery KJ; Vine AM; Witkover A; Nowak MA; Wodarz D; Usuku K; Osame M
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):691-700. PubMed ID: 10365395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic stability of human T lymphotropic virus type I despite antiviral pressures by CTLs.
    Kubota R; Hanada K; Furukawa Y; Arimura K; Osame M; Gojobori T; Izumo S
    J Immunol; 2007 May; 178(9):5966-72. PubMed ID: 17442981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Enose-Akahata Y; Jacobson S
    Retrovirology; 2019 Nov; 16(1):35. PubMed ID: 31783764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.